Space Travel News  
EPIDEMICS
China approves world's first inhalable Covid-19 vaccine
by AFP Staff Writers
Beijing (AFP) Sept 5, 2022

Chinese drug regulators have approved the world's first inhalable Covid-19 vaccine, made by Tianjin-based manufacturer CanSino Biologics, boosting the company's share price by seven percent on Monday.

The National Medical Products Administration gave the go-ahead for the vaccine for emergency use as a booster, the company said in a statement to the Hong Kong Stock Exchange on Sunday.

Following the announcement, company shares surged 14 percent on Monday morning before closing 7.1 percent higher than their opening value.

The needle-free vaccine -- which can be stored and administered more easily than intramuscular jabs -- will be given through a nebuliser, the company said.

"The approval will have a positive impact on the company's performance if the vaccine is subsequently purchased and used by relevant government agencies," the statement added.

The company did not offer details on when the adenovirus-vectored vaccine will be made available for public use.

There is no publicly available verified or peer-reviewed data on the efficacy of the new vaccine.

Scientists in several countries including Cuba, Canada and the United States are also trialling inhalable Covid-19 vaccines.

China has so far approved eight other locally manufactured injectable vaccines since 2020.

But the country's drug administrator is yet to greenlight any foreign vaccines, including mRNA shots produced by Pfizer/BioNTech or Moderna that have better efficacy rates compared to other types of vaccines.

China is the only major economy sticking to a zero-Covid policy, disrupting travel and businesses.

Officials across the country are now under pressure to curb local virus flare-ups ahead of a key political meeting next month.

The southern tech hub of Shenzhen, with more than 18 million residents, imposed a weekend lockdown in most parts of the city on Saturday, while more than 21 million people in the southwestern metropolis of Chengdu are undergoing mass testing from Monday through Wednesday.

China has administered over 3.4 billion Covid shots, the National Health Commission said Monday without offering details on the percentage of the population vaccinated.

prw/je/aha

PFIZER

CanSino Biologics Inc.

BioNTech


Related Links
Epidemics on Earth - Bird Flu, HIV/AIDS, Ebola


Thanks for being here;
We need your help. The SpaceDaily news network continues to grow but revenues have never been harder to maintain.

With the rise of Ad Blockers, and Facebook - our traditional revenue sources via quality network advertising continues to decline. And unlike so many other news sites, we don't have a paywall - with those annoying usernames and passwords.

Our news coverage takes time and effort to publish 365 days a year.

If you find our news sites informative and useful then please consider becoming a regular supporter or for now make a one off contribution.
SpaceDaily Contributor
$5 Billed Once


credit card or paypal
SpaceDaily Monthly Supporter
$5 Billed Monthly


paypal only


EPIDEMICS
Millions locked down in China's Chengdu over Covid outbreak
Beijing (AFP) Sept 2, 2022
Millions were stuck at home in China's Chengdu on Friday after a handful of Covid-19 cases brought the megacity to a standstill. Supermarket shelves were stripped bare this week as locals in the city - a powerhouse economic hub in China's southwest that is home to 21 million people - feared a repeat of the months-long lockdown in the eastern megalopolis of Shanghai earlier this year. Long lines of residents queued for mandatory testing, while videos verified by AFP showed supermarket shelves c ... read more

Comment using your Disqus, Facebook, Google or Twitter login.



Share this article via these popular social media networks
del.icio.usdel.icio.us DiggDigg RedditReddit GoogleGoogle

EPIDEMICS
EPIDEMICS
MIT's MOXIE experiment reliably produces oxygen on Mars

An Unexpected Stop during Sols 3580-3581

MAVEN and EMM make first observations of patchy proton aurora at Mars

A Whole New World - Sols 3578-3579

EPIDEMICS
NASA Moon launch to attract up to 400,000 visitors

Thermophysical properties of lunar farside regolith with in-situ temperature measurement by Chang'E-4

UCL team maps moon's surface for NASA missions

'Sight to behold': tourists flock to Florida for Moon rocket launch

EPIDEMICS
NASA's Juno Mission Reveals Jupiter's Complex Colors

The PI's Perspective: Extending Exploration and Making Distant Discoveries

Uranus to begin reversing path across the night sky on Wednesday

Underwater snow gives clues about Europa's icy shell

EPIDEMICS
JWST makes first unequivocal detection of carbon dioxide in an exoplanet atmosphere

An extrasolar world covered in water

Webb detects carbon dioxide in exoplanet atmosphere

Webb telescope finds CO2 for first time in exoplanet atmosphere

EPIDEMICS
NASA Moon rocket ready for second attempt at liftoff

NASA says weather, SLS rocket look good for Artemis I launch on Saturday

NASA scrubs launch of giant Moon rocket, may try again Friday

New launch attempt Saturday for NASA's Moon rocket: official

EPIDEMICS
Plant growth in China's space lab in good condition

Energy particle detector helps Shenzhou-14 crew conduct EVAs

China conducts spaceplane flight test

103rd successful rocket launch breaks record

EPIDEMICS
DART team confirms orbit of targeted asteroid

Madrid meteor's cometary origins unearthed

Dust grains older than our sun found in Asteroid Ryugu samples

NASA's Lucy team discovers moon around asteroid Polymele









The content herein, unless otherwise known to be public domain, are Copyright 1995-2024 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. General Data Protection Regulation (GDPR) Statement Our advertisers use various cookies and the like to deliver the best ad banner available at one time. All network advertising suppliers have GDPR policies (Legitimate Interest) that conform with EU regulations for data collection. By using our websites you consent to cookie based advertising. If you do not agree with this then you must stop using the websites from May 25, 2018. Privacy Statement. Additional information can be found here at About Us.